February 18, 2000


Thursday May 18

7 a.m.-8:30 a.m.

Industry-Supported Symposia

IS40. Why Do Anxious People Become Depressed? The Role of Stress Supersensitivity (Part 2) Supported by Wyeth-Ayerst Laboratories

A. The HPA Axis and the Pathophysiology of Depression Dominique L. Musselman, M.D.

B. Antidepressants: Why Are They Anxiolytic Also? Alan Frazer, Ph.D.

C. Management of Complex Anxiety and Depression Philip T. Ninan, M.D.

IS41. Clinical Challenges and Choices in the Treatment of ADD/ADHD (Part 2) Supported by Shire Richwood

A. Emerging Technologies for the Treatment of ADD/ADHD James Swanson, Ph.D.

B. Evidence-Based Stimulant Treatments for ADHD Laurence L. Greenhill, M.D.

IS42. The Mental Health of Women and Children (Part 2) Supported by U.S. Pharmaceuticals, Pfizer Inc.

A. Considerations Regarding the Course of Social Anxiety Disorder: Considerations for Early Intervention Stanley P. Kutcher, M.D.

B. Family Violence in America Bruce D. Perry, M.D.

IS43. The Interface of Neuropsychiatric Disorders in the Elderly (Part 2) Supported by Eli Lilly and Company

A. Assessment of Cognition in Schizophrenia: What We Learn from Alzheimer’s Disease and Other Dementias Richard C. Mohs, Ph.D.

B. Treatment of Cognitive Deficits in Schizophrenia with Antipsychotic Drugs Scot E. Purdon, Ph.D.

C. Translating Academia’s Impact on the Future of Clinical Practice Barry D. Lebowitz, Ph.D.

IS44. Breaking the Cycle: Novel Treatments in Bipolar Disorder (Part 2) Supported by Janssen Pharmaceutica and Research Foundation

A. Treating Depression in Bipolar Disorder Dwight L. Evans, M.D.

B. The Use of Atypical Antipsychotic Agents in Bipolar Disorder S. Nassir Ghaemi, M.D.

7:30 a.m.-2 p.m.

Registration/Course Enrollment Open

8 a.m.-Noon

CME Courses 100-103

9 a.m.-10:30 a.m.

Clinical Case Conference 4. Tanya R. Cheevers, M.D., on Women and Addiction: Enhancing Motivation for Change (open to APA members only)

Discussion Groups

17. Richard J. Goldberg, M.D., on Financial Management Challenges for Psychiatry 2000

18. Keh-Ming Lin, M.D., on Individual and Ethnic Variations in Psychotropic Responses

Lectures

L24. To Be Announced Ronald L. Numbers, Ph.D., APA’s Benjamin Rush Award Lecture

L25. City of One: A Memoir of Childhood Loss and Its Aftermath Francine Cournos, M.D., Distinguished Psychiatrist Lecture Series

Master Education Clinical Consultations

14. David A. Goldberg, M.D., on Focal Psychotherapy Strategies (open to APA members only)

15. Charles F. Reynolds III, M.D., on Assessment and Treatment of Mood and Sleep Disorders in Old Age (open to APA members only)

New Research Oral/Slide Sessions 13-14

Component Workshops

CW43. Antihomosexual Bias in Clinical Settings APA New York County District Branch’s Committee on Gay and Lesbian Issues Co-Chairpersons: Kenneth B. Ashley, M.D., and John A. Gosling, M.D.

CW44. Spirituality and Religion in Substance Abuse Treatment APA Committee on Treatment Services for Addicted Patients Chairperson: Marianne T. Guschwan, M.D.

CW45. Update on the Practice Guideline on Borderline Personality Disorder APA Steering Committee on Practice Guidelines Co-Chairpersons: John S. McIntyre, M.D., and John M. Oldham, M.D.

CW46. Documenting Psychotherapy: Principles and Dilemmas APA Commission on Psychotherapy by Psychiatrists and APA Committee on Confidentiality Chairperson: Norman A. Clemens, M.D.

CW47. Private Practice: Change and Opportunity APA Committee on Private Practice Chairperson: Michael C. Hughes, M.D.

CW48. Psychiatric Scope of Practice and Its Implications APA Committee on Workforce Issues Chairperson: Nyapati R. Rao, M.D.

CW49. The Healing Ways of the Anishinaabe Ojibwe People APA Committee of American Indian, Alaska Native, and Native Hawaiian Psychiatrists Co-Chairpersons: Robert C. Palmer, M.D., and Blackwolf Jones, M.S.

CW50. Doctors and Inmates: Psychiatric Challenge and Opportunity APA Consortium on Special Delivery Settings Co-Chairpersons: Charles A. Meyer Jr., M.D., and Cassandra F. Newkirk, M.D.

CW51. Innovative Therapeutics in Consultation-Liaison Psychiatry APA Committee on Consultation-Liaison Psychiatry and Primary Care Education Co-Chairpersons: Francisco Fernandez, M.D., and James L. Griffith, M.D.

Issue Workshops

IW72. Forests, Trees, and Therapy: Psychiatry’s Pastoral Role Chairperson: Rabbi Terry Bard, Ph.D.

IW73. Hidden Abuse: Exploitation of the Impaired Elderly Chairperson: Michael J. Tueth, M.D.

IW74. Preventing Incarceration of Mentally Ill Adults Chairperson: J. Steven Lamberti, M.D.

IW75. Principles of Effective State Legislative Liaison Co-Chairpersons: Stephen M. Soltys, M.D., and Geoffrey J. Mason, M.P.A.

IW76. Termination Issues in a Psychopharmacology Clinic Chairperson: Toby D. Goldsmith, M.D.

IW77. 21st Century and Community Psychiatry Chairperson: Kenneth S. Thompson, M.D.

IW78. How to Make an Effective Psychiatric Presentation Chairperson: Phillip J. Resnick, M.D.

IW79. Child-Adolescent Substance Use Disorders National Institute on Alcohol Abuse and Alcoholism Co-Chairpersons: Catherine A. Nageotte, M.D., and Kevin M. Murphy, L.C.S.W.

IW80. Guerilla Interviewing: A Guide to Assessment Chairperson: Gary A. Chaimowitz, M.D.

IW81. PTSD and Memory: The Debate Goes International Chairperson: Landy F. Sparr, M.D.

IW82. Cultural Issues in the Doctor-Patient Relationship Co-Chairpersons: Jon M. Streltzer, M.D., and Richard J. Castillo, Ph.D.

IW83. Applying Narrative Therapy in Psychiatric Practice Co-Chairpersons: Shoshana R. Sokoloff, M.D., and SuEllen I. Hamkins, M.D.

9 a.m-11 a.m.

Media Sessions

Session 27. The Stigma of Mental Illness/The Tragedy of Suicide: Public and Professional Education

39. Stigma. . .In Our Work, In Our Lives

40. No Easy Way

Session 28. American Indian Mascots in Sports: Mental Health Implications

41. In Whose Honor

9 a.m.-4 p.m.

CME Courses 104-105

11 a.m.-12:30 p.m.

Discussion Groups

19. Elizabeth B. Weller, M.D., on Mood Disorders in Children and Adolescents

20. Richard T. Suchinsky, M.D., on Emerging Issues in the Treatment of Addictive Disorders National Institute on Alcohol Abuse and Alcoholism

Lectures

L26. Off the Wall: A Quarter Century of Opportunities for Creativity in Psychiatric Education Leah J. Dickstein, M.D., APA’s Seymour D. Vestermark Award Lecture

L27. The Human Genome Project, Medicine, and Society Francis S. Collins, M.D., Frontiers of Science Lecture Series

Medical Update 4. Robert Jarvik, M.D., on Human Engineering of the Jarvik 2000 Heart for Psychosocial Acceptability

Research Consultation 3. Judith H.L. Rapoport, M.D., on Childhood Psychoses

Scientific and Clinical Report Sessions

Session 28. Difficult Issues in Forensic Psychiatry

83. Detection of Malingering with the Rey Auditory Verbal Learning Test (RAVLT) David A. Alcorn, M.D.

84. Culture, English Proficiency, and Trial Outcome S. Peter Kim, M.D.

85. Residential Treatment Unit: A Two-Year Study Cristinel M. Coconcea, M.D.

Session 29. Diagnosis and Treatment of Bipolar Illness: Part 2

86. Bipolar Depressive Mixed State: Delineation of a Neglected Condition Giulio Perugi, M.D.

87. From Cell to Patient: Are There Common Effects on Membrane Currents by Anticonvulsants Efficacious in Treating Bipolar Rapid Cycling? Heinz C. Grunze, M.D.

88. Anticonvulsant Prophylaxis in a Naturalistic Clinical Setting Eric D. Peselow, M.D.

Session 30. Treatment Issues and Mood Disorders

89. Double-Blind Study of High-Dose Fluoxetine Versus Lithium or Desipramine Augmentation of Fluoxetine in Partial and Nonresponders to Fluoxetine Maurizio Fava, M.D.

90. Cholesterol Levels in Major Depressive Disorder and Response to Fluoxetine Treatment Shamsah B. Sonawalla, M.D.

91. SSRIs and Time of Onset of Antidepressant Action Andrew A. Nierenberg, M.D.

Session 31. Diagnostic and Outcome Issues in Depression

92. Melancholia and Axis II Comorbidity Joyce R. Tedlow, M.D.

93. Clinical and Demographic Differences of Neurotic Versus Non-Neurotic Depressives Timothy J. Petersen, Ph.D.

94. Global Assessment Function and Length of Stay as Predictors of Outcome in Depression John W. Goethe, M.D.

Session 32. Anxiety: Symptom or Disorder?

95. Augmentation with Noradrenergic Agents for Treatment-Resistant Depression in Patients with OCD Catherine L. Mancini, M.D.

96. Dreams in PTSD: A Review Milton Kramer, M.D.

97. Gender Differences: Drug Abuse and Related Anxiety Istvan Kecskes, M.D.

Session 33. Hormones and Psychiatry

98. Treatment of Major Depression in Perimenopausal Women: Results from a Randomized, Double-Blind, Placebo-Controlled Trial of 17B-Oestradiol Claudio Soares, M.D.

99. Cortisol and Acute Stress in Women with PTSD Cheryl Koopman, Ph.D.

100. Neuroactive Steroids in Chronic Fatigue Syndrome Beverley E. Pearson-Murphy, Ph.D.

Session 34. Comorbidity in Mood Disorders

101. Psychiatric Comorbidity in Patients Presenting for In-Vitro Fertilization Rajesh M. Parikh, M.D.

102. Psychotherapy of Psychosis Jon E. Gudeman, M.D.

103. Familial Aggregation of Eating and Mood Disorders James I. Hudson, M.D.

Session 35. Treatment Issues in Schizophrenia

104. Recovery from Schizophrenia Joseph Ventura, Ph.D.

105. Antipsychotic Adherence Among Outpatients Mark R. Vanelli, M.D.

106. Adjunctive Valproate in Schizophrenia Leslie L. Citrome, M.D.

Session 36. Course of Illness in Schizophrenia

107. Neurocognition and Recovery in Schizophrenia Thomas E. Smith, M.D.

108. Antisocial Comorbidity and Homelessness Carol L.M. Caton, Ph.D.

109. Anhedonia in Schizophrenia: Longitudinal Analyses Ellen S. Herbener, Ph.D.

Component Workshops

CW52. Fearing and Welcoming the New Millennium APA Committee on History and Library Chairperson: Richard J. Thurrell, M.D.

CW53. Teacher/Learner: Boundaries in Medical Education APA Rhode Island Psychiatric Society Co-Chairpersons: Patricia R. Recupero, M.D. and Alison M. Heru, M.D.

Issue Workshops

IW84. Doctor-Patient Relationship and Malpractice Suits Co-Chairpersons: Sara C. Charles, M.D., and Miguel A. Leibovich, M.D.

IW85. Avoiding Legal Risks in Psychopharmacology Chairperson: David W. Preven, M.D.

IW86. The Physician-Patient Relationship: Not Just Medication Chairperson: Eugene J. Fierman, M.D.

IW87. Intensive Outpatient Programs Chairperson: Anand Pandya, M.D.

IW88. Stalking and Cyberstalking: A Risk Assessment Co-Chairpersons: John M. Deirmenjian, M.D., and Phillip J. Resnick, M.D.

IW89. Aim for the Right Target: Focus on Motivation Chairperson: Mary C. Cole, M.S.W.

IW90. Spiritual Issues in End-of-Life Care Co-Chairpersons: Christina M. Puchalski, M.D., and William Breitbart, M.D.

IW91. Cognitive Therapy for Personality Disorders Chairperson: Judith S. Beck, Ph.D.

IW92. Neuroanatomy and Neurophysics of the Unconscious Co-Chairpersons: Vincenzo R. Sanguineti, M.D. and Stuart R. Hameroff, M.D.

11 a.m.-2 p.m.

Media Sessions

Session 29. From the Bioethics of U.S. Genetic Counseling to the Practice of Vietnamese Indigenous Healing

42. Genetic Dilemmas in Primary Care

43. Tiger’s Apprentice

Session 30. End-of-Life Care: Professional and Patient Perspectives

44. The Vanishing Line

45. Death: A Love Story

Noon - 1:30 p.m.

Forums

9. Here’s Looking at You! Self-Reflection in Psychotherapy Chairperson: Norman A. Clemens, M.D.

10. Substance Abuse: An International Perspective Chairperson: Rodrigo A. Muñoz, M.D.

Noon-2 p.m.

New Research Poster Session 15

2 p.m.-5 p.m.

Symposia

S83. The Challenges of Treating Postpartum Depression

A. Sexual Abuse in Pregnant and Postpartum Women Shaila Misri, M.D.

B. Work Discrimination by Gender and Postpartum Depression Susanne I. Steinberg, M.D.

C. The Effects of Childbearing on Sleep, Mood, and Cognitive Function Michael W. O’Hara, Ph.D.

D. Seasonal and Sleep Changes in Postpartum Depression Jan Berle, M.D.

E. Decision Making for Treatment of Depression in Pregnancy Katherine L. Wisner, M.D.

S84. NMS 1960-2000: 40 Years of Progress Neuroleptic Malignant Syndrome Information Service

A. Analysis of the North American NMS Information Service Database Stanley N. Caroff, M.D.

B. Novel Antipsychotics and NMS: The United Kingdom’s NMS Database Dora D. Kohen, M.D.

C. Catatonia and NMS: What Is the Connection? Andrew J. FrancisJr., M.D.

D. Hypothermia Syndromes in Psychiatry: One or Many? Ronald J. Gurrera, M.D.

E. Central Dopamine Hypoactivity and the Pathogensis of NMS Stephan C. Mann, M.D.

S85. Therapeutic Relationship and Psychotherapy Efficacy

A. A Comparative Analysis of Therapy Outcome and Failure Arnold Winston, M.D.

B. A Comparative Analysis of the Therapeutic Alliance J. Christopher Muran, Ph.D.

C. Interpersonal and Attachment Perspectives on the Alliance and Outcome Lisa Wallner-Samstag, Ph.D.

D. Therapeutic Climate in Group Treatments for Dually Diagnosed Patients Richard N. Rosenthal, M.D.

S86. Comorbid Disease and Mortality in Schizophrenia

A. Physical Comorbidity in Schizophrenia Povl Munk-Jorgensen, Ph.D.

B. HIV and Schizophrenia Francine Cournos, M.D.

C. Diabetes and Schizophrenia Lisa B. Dixon, M.D.

D. Weight Gain and Antipsychotics Peter F. Buckley, M.D.

E. Mortality and Polypharmacy in Schizophrenia John L. Waddington, D.Sc.

S87. The Body Self and Its Disorders

A. The Body Self: An Overview Gary M. Rodin, M.D.

B. Culture and the Body Self Melanie A. Katzman, Ph.D.

C. BDD: New Data on an Old Disorder Katharine A. Phillips, M.D.

D. Muscle Dysmorphia in Male Weightlifters Roberto Olivardia, M.A.

E. Body Self-Esteem in Cancer Mark R. Katz, M.D.

F. Motivations for and Psychological Effects of Changing the Body Marcia K. Goin, M.D.

S88. Health Services Use in Schizophrenia: New Data

A. Older Veterans with Schizophrenia: Three-Year Treatment Outcomes Frederic C. Blow, Ph.D.

B. Age-Related Comparison of Health Resource Utilization in Women Admitted to an Acute-Care State Psychiatric Facility Martha Sajatovic, M.D.

C. ACT Versus Standard Case Management Clients Use Different Services Susan M. Essock, Ph.D.

D. Are Atypical Antipsychotics Cost Effective? Jonathan P. Lacro, Pharm.D.

E. Inappropriate Nursing Home Use by Elderly with Schizophrenia Stephen J. Bartels, M.D.

S89. Clinical Applications of Psychiatric Genetics

A. Clinical Applications of Genetic Knowledge: An Overview Stephen V. Faraone, Ph.D.

B. Applications to Clinical Issues in Schizophrenia Ming T. Tsuang, M.D.

C. Applications to Anxiety Disorders Joseph Biederman, M.D.

D. Psychiatric Genetic Counseling Debby Wen Tsuang, M.D.

S90. Doctor-Patient Relationship: Past, Present, and Future

A. Doctor-Patient Relations in Nazi Germany and the Fate of Patients Irwin N. Hassenfeld, M.D.

B. Tarasoff and the Psychiatrist-Patient Relationship Paul S. Appelbaum, M.D.

C. The Placebo Effect in the Contemporary Doctor-Patient Relationship Walter A. Brown, M.D.

D. Men Doctors/Women Patients: Problem or Potential? Nada L. Stotland, M.D.

S91. Managed Care and the Patient-Doctor Relationship

A. Consumer Technology and Organized Systems of Care Mary Jane England, M.D.

B. The Changing Nature of the Doctor-Patient Relationship Alan A. Stone, M.D.

C. Developing a Communitarian Ethic James Sabin, M.D.

D. The African-American Experience in Managed Care Donna M. Norris, M.D.

E. The Patient-Doctor Relationship: What Happened? Leon Eisenberg, M.D.

S92. New Developments in Interpersonal Psychotherapy

A. Overview of Interpersonal Psychotherapy John C. Markowitz, M.D.

B. Treating Dysthymia in Primary Care: Sertraline Versus Interpersonal Psychotherapy Meir Steiner, M.D.

C. Maintenance Interpersonal Psychotherapy in Late-Life Depression Charles F. Reynolds III, M.D.

D. Interpersonal Psychotherapy for Perinatal Depression Scott P. Stuart, M.D.

E. Interpersonal Psychotherapy for Social Phobia Joshua D. Lipsitz, Ph.D.

S93. Update on the Etiology, Treatment, Diagnosis, and Comorbidity of Panic Disorder

A. Panic Disorder Across the Life Span R. Bruce Lydiard, M.D.

B. Recent Advances in the Biology of Panic Disorder Donald F. Klein, M.D.

C. Panic Disorder in a Clinical Setting: Issues of Comorbidity Eric D. Peselow, M.D.

D. Cognitive-Behavioral Therapy for Panic Disorder Mark Sisti, Ph.D.

E. Panic Disorder: A First-Person Account Mary T. Guardino, B.A.

S94. The Difficult-to-Treat Psychiatric Patient

A. The Difficult-to-Treat Bipolar Patient Frederick K. Goodwin, M.D.

B. Treatment-Resistant Schizophrenia Ronald W. Pies, M.D.

C. The Difficult-to-Treat PTSD Patient Randall D. Marshall, M.D.

D. The Difficult-to-Treat Eating Disordered Patient Katherine A. Halmi, M.D.

S95. Treatment of Substance Use Disorders in Routine Clinical Practice

A. Addiction and Co-Occuring Psychiatric Disorders Douglas M. Ziedonis, M.D.

B. Use of ASAM Criteria for SUD Patient Placement David R. Gastfriend, M.D.

C. Substance Use Disorders in Routine Psychiatric Practice Ivan D. Montoya, M.D.

D. Treatment for Pregnant and Postpartum Drug-Dependent Women Dace Svikis, Ph.D.

E. Matching Patients to Substance Use Treatments Thomas McLelland, Ph.D.

F. Child Welfare Referral to Substance Abuse Treatment Kathleen M. Carroll, Ph.D.

S96. Frontiers in Clinical Alcoholism Treatment/Behavioral National Institute on Alcohol Abuse and Alcoholism

A. Enhancing Motivation for Change in Alcoholism Treatment Carlo C. Diclemente, Ph.D.

B. Cognitive-Behavioral Therapy: Status and New Directions Gerard J. Conners, Ph.D.

C. Couples Therapy for Alcoholism and Drug Abuse Timothy J. O’Farrell, Ph.D.

S97. Depersonalization Disorder: An Overview

A. Feeling Unreal: Introduction to Depersonalization Disorder Daphne Simeon, M.D.

B. Autonomic Response in Depersonalization Disorder Mauricio Sierra, M.D.

C. Feeling Unreal: The Neuropsychology of Depersonalization Orna Guralnik, Psy.D.

D. Depersonalization: Thinking Without Feeling Mary L. Phillips, M.D.

S98. Urban Mental Health: International Perspective

A. Urbanization and Mental Health: An Overview of Issues, Research, and Directions Anthony J. Marsella, Ph.D.

B. Mega Cities and Mental Health Giovanni Caracci, M.D.

C. Urbanization and Mental Health: A Case Study in Kobe Shinfuku Naotaka, M.D.

D. Rings of Poverty: The City Around the City Roberto E. Chaskel, M.D.

S99. Psychodynamic Education: Should We? Can We? Do We?

A. Current Issues in Psychotherapy Education Elizabeth Auclincloss

B. Missouri Psychotherapy Modules Bernard D. Beitman, M.D.

C. Why Include Individual Supervision in Psychotherapy Education? James W. Lomax II, M.D.

D. Putting Psychiatry to the Test: Measuring Therapy Skills Linda S. Mullen, M.D.

S100. Impact of Older Age on HIV

A. Age, Cognitive Motor Impairment and Disorder, and Functional Status in HIV Karl Goodkin, M.D.

B. The Effects of Age on Cognition in HIV Infection Frances L. Wilkie, Ph.D.

C. Psychological Symptoms Among Older Men Living with HIV and AIDS Timothy G. Heckman, Ph.D.

D. Older Caregivers of HIV-Affected Kin: Impact on Affect and Care Nathan L. Linsk, Ph.D.

S101. Complementary Medicines and the Psychiatrist

A. Homeopathy for the Difficult-to-Treat Psychiatric Patient Edward B. Gogek, M.D.

B. What the Psychiatrist Needs to Know About Herbs Hyla R. Cass, M.D.

C. Acupuncture and Psychiatry John M. Ackerman, M.D.

S102. Violent Patients: Assessment, Management, and Treatment

A. Violence and Mental Illness: An Overview W. Walter Menninger, M.D.

B. Assessment and Management of the Violent Patient Carl C. Bell, M.D.

C. Psychopharmacological Treatments for Violence Stuart C. Yudofsky, M.D.

D. New Developments in the Duty to Protect James C. Beck, M.D.

E. Juvenile Violence: Causes and Effects Charles L. Scott, M.D.

F. Violence in the Workplace Ronald Schouten, M.D., J.D.

S103. Beyond Types: Examining the Evidence for a Dimensional Model of OCD

A. Symptom Subtypes and Family History in OCD Margaret A. Richter, M.D.

B. Examining the Evidence for a Dimensional of OCD Laura J. Summerfeldt, Ph.D.

C. OCD Phenotypes: The Role of the Sensory Phenomena Euripedes C. Miguel, M.D.

D. Issues in the Genetics of OCD Michele T. Pato, M.D.

S104. Outcomes of Depression in Europe: The ODIN Project

A. The ODIN Project: Study, Design, and Instruments Jose Luis Vazquez-Barquero, M.D.

B. The ODIN Project: Epidemiology and Prevalence Ville Lehtinen, M.D.

C. Social Support, Life Events, and Prevalence of Depression Steffen Dalgard, D.M.

D. Impact of Personality on Depression: Risk and Outcome Patricia R. Casey, M.D.

E. Trial of Psychological Interventions in the Community Christopher F. Dowrick, M.D.

S105. Molecules to Mind: Psychiatry at the Millennium

A. DNA Information Will Individualize Patient Care James L. Kennedy, M.D.

B. Genetic Susceptibility to Psychoses Wade H. Berrettini, M.D.

C. Weight Dysregulation: Symptom and Side Effect Julio Licinio, M.D.

D. Stress, Immunity, and Behavior Esther M. Sternberg, M.D.

E. Long-Term Medical Consequences of Depression Philip W. Gold, M.D.

S106. Pharmacotherapy of Impulsive Personality Disorders

A. The Use of Mood Stabilizers in the Treatment of Impulsivity Charles L. Bowden, M.D.

B. Medication Management of Impulsive Substance Abuse Herbert D. Kleber, M.D.

C. Pharmacotherapy of Patients with Impulsive Personality Disorders Paul S. Links, M.D.

D. Longitudinal Patterns of Medication Utilization in BPD John M. Oldham, M.D.

E. Cognitive Therapy Techniques to Enhance Medication Compliance Judith S. Beck, Ph.D.